HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMC 3425572)

Published in PLoS One on August 22, 2012

Authors

Chaeyoung Kim1, Heesun Choi, Eun Sun Jung, Wonik Lee, Soojung Oh, Noo Li Jeon, Inhee Mook-Jung

Author Affiliations

1: Department of Biochemistry and Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.

Articles citing this

Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet (2013) 1.05

Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat Commun (2014) 1.02

Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology (2013) 0.93

Regulation of autophagy and mitophagy by nutrient availability and acetylation. Biochim Biophys Acta (2014) 0.88

Acetylation: a new key to unlock tau's role in neurodegeneration. Alzheimers Res Ther (2014) 0.86

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget? ChemMedChem (2015) 0.86

The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol (2014) 0.81

Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition. J Neurosci (2014) 0.80

Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease. Front Cell Neurosci (2015) 0.80

Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport. Mol Neurodegener (2017) 0.75

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease. Neurotherapeutics (2016) 0.75

HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging. Neuropharmacology (2017) 0.75

Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease. Brain Behav (2015) 0.75

Diverse molecular targets for therapeutic strategies in Alzheimer's disease. J Korean Med Sci (2014) 0.75

An acetylation-phosphorylation switch that regulates tau aggregation propensity and function. J Biol Chem (2017) 0.75

Discovery of a fluorescent probe with HDAC6 selective inhibition. Eur J Med Chem (2017) 0.75

The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease. Transl Neurodegener (2017) 0.75

Articles cited by this

HDAC6 is a microtubule-associated deacetylase. Nature (2002) 12.76

Culturing hippocampal neurons. Nat Protoc (2007) 8.34

Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol (2006) 6.20

Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science (2005) 5.49

Cytoskeletal dynamics and transport in growth cone motility and axon guidance. Neuron (2003) 5.19

Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39

Microfluidic culture platform for neuroscience research. Nat Protoc (2006) 4.02

HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J (2003) 3.96

Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci (2007) 3.79

Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A (2008) 3.68

Tubulin modifications and their cellular functions. Curr Opin Cell Biol (2008) 3.52

Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci (2000) 3.48

Mitochondria in neuroplasticity and neurological disorders. Neuron (2008) 3.35

Axonal mitochondrial transport and potential are correlated. J Cell Sci (2004) 3.15

Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J (2005) 2.91

Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med (2011) 2.60

Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci (2010) 2.55

Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc (2010) 2.50

Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A (2010) 2.45

Moving mitochondria: establishing distribution of an essential organelle. Traffic (2007) 2.44

Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci (2006) 2.10

The relationship between mitochondrial shape and function and the cytoskeleton. Biochim Biophys Acta (2006) 2.02

Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci (2010) 2.00

Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J Cell Sci (2004) 1.92

Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol (2006) 1.72

HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One (2010) 1.63

Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci (2010) 1.62

Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J Neuropathol Exp Neurol (1996) 1.62

Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci (2009) 1.55

Post-translational modifications of tubulin in the nervous system. J Neurochem (2009) 1.44

Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem (2008) 1.38

Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim Biophys Acta (2011) 1.37

Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox Signal (2007) 1.35

Two catalytic domains are required for protein deacetylation. J Biol Chem (2005) 1.31

Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener Dis (2010) 1.27

Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J Cell Biol (2006) 1.20

Microtubule modification: acetylation speeds anterograde traffic flow. Curr Biol (2007) 1.13

Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One (2012) 1.12

GSK-3 in Neurodegenerative Diseases. Int J Alzheimers Dis (2011) 0.97

Abeta promotes Alzheimer's disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J Neurochem (2010) 0.91

Amyloid-β-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway. J Alzheimers Dis (2011) 0.90

Accumulation of phosphorylated beta-catenin enhances ROS-induced cell death in presenilin-deficient cells. PLoS One (2009) 0.84

Histone deacetylase inhibitors induce mitochondrial elongation. J Cell Physiol (2012) 0.80

Articles by these authors

A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods (2005) 7.62

Microfluidic culture platform for neuroscience research. Nat Protoc (2006) 4.02

Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip (2005) 3.33

The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J (2007) 2.37

Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng (2005) 2.15

Patterned cell culture inside microfluidic devices. Lab Chip (2004) 1.89

Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. Biochem Biophys Res Commun (2004) 1.83

Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip (2009) 1.77

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76

Generation of stable concentration gradients in 2D and 3D environments using a microfluidic ladder chamber. Biomed Microdevices (2007) 1.75

Microfluidic Multicompartment Device for Neuroscience Research. Langmuir (2003) 1.72

A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis. Biomed Microdevices (2006) 1.72

Axonal elongation triggered by stimulus-induced local translation of a polarity complex protein. Nat Cell Biol (2009) 1.71

Biological applications of microfluidic gradient devices. Integr Biol (Camb) (2010) 1.67

Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip (2013) 1.64

Unique dielectric properties distinguish stem cells and their differentiated progeny. Stem Cells (2007) 1.62

Vascular mimetics based on microfluidics for imaging the leukocyte--endothelial inflammatory response. Lab Chip (2007) 1.62

Generation of dynamic temporal and spatial concentration gradients using microfluidic devices. Lab Chip (2004) 1.60

Fluorescent and photo-oxidizing TimeSTAMP tags track protein fates in light and electron microscopy. Nat Neurosci (2012) 1.60

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2010) 1.51

Generation of stable complex gradients across two-dimensional surfaces and three-dimensional gels. Langmuir (2007) 1.48

Caregiver's education level and child's dental caries in African Americans: a path analytic study. Caries Res (2015) 1.43

Neutrophil migration in opposing chemoattractant gradients using microfluidic chemotaxis devices. Ann Biomed Eng (2005) 1.41

A microfluidic chamber for analysis of neuron-to-cell spread and axonal transport of an alpha-herpesvirus. PLoS One (2008) 1.31

Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum Mol Genet (2006) 1.30

A microfluidic multi-injector for gradient generation. Lab Chip (2006) 1.27

A hybrid microfluidic-vacuum device for direct interfacing with conventional cell culture methods. BMC Biotechnol (2007) 1.25

Robust spatial sensing of mating pheromone gradients by yeast cells. PLoS One (2008) 1.24

In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices. Lab Chip (2012) 1.23

SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23

Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases. Hum Pathol (2010) 1.22

Diagnosis of gastric epithelial neoplasia: Dilemma for Korean pathologists. World J Gastroenterol (2011) 1.20

Dielectrophoresis switching with vertical sidewall electrodes for microfluidic flow cytometry. Lab Chip (2007) 1.20

Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. Biotechnol Bioeng (2008) 1.20

Microfluidic chambers for cell migration and neuroscience research. Methods Mol Biol (2006) 1.19

UBR2 mediates transcriptional silencing during spermatogenesis via histone ubiquitination. Proc Natl Acad Sci U S A (2010) 1.17

Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol (2010) 1.16

RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells (2011) 1.15

Neurotrophin-mediated dendrite-to-nucleus signaling revealed by microfluidic compartmentalization of dendrites. Proc Natl Acad Sci U S A (2011) 1.15

β-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging (2009) 1.13

Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One (2012) 1.12

ERK1/2 is an endogenous negative regulator of the gamma-secretase activity. FASEB J (2005) 1.09

Advances in microfluidics-based experimental methods for neuroscience research. Lab Chip (2013) 1.09

Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging (2003) 1.08

Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci (2010) 1.08

Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling. Neurobiol Aging (2011) 1.07

Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling. J Neurosci (2012) 1.06

Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis (2004) 1.05

Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev (2005) 1.03

Micro-scale and microfluidic devices for neurobiology. Curr Opin Neurobiol (2010) 1.02

Preparing e18 cortical rat neurons for compartmentalization in a microfluidic device. J Vis Exp (2007) 1.02

Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease. PLoS One (2012) 1.01

Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2012) 1.01

Non-plasma bonding of PDMS for inexpensive fabrication of microfluidic devices. J Vis Exp (2007) 0.99

Variation in effective stimulus patterns for induction of long-term potentiation across different layers of rat entorhinal cortex. J Neurosci (2002) 0.98

MRI of chondromyxoid fibroma. Acta Radiol (2011) 0.97

Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. J Alzheimers Dis (2012) 0.97

IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia (2007) 0.97

Mixed exocrine and endocrine carcinoma in the stomach: a case report. J Gastric Cancer (2011) 0.96

Microfluidic and compartmentalized platforms for neurobiological research. Crit Rev Biomed Eng (2011) 0.95

Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-beta exposure. J Neurochem (2004) 0.95

Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice. J Alzheimers Dis (2011) 0.95

Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell (2007) 0.95

Two distinct filopodia populations at the growth cone allow to sense nanotopographical extracellular matrix cues to guide neurite outgrowth. PLoS One (2010) 0.95

Recreating the perivascular niche ex vivo using a microfluidic approach. Biotechnol Bioeng (2010) 0.94

External force-assisted cell positioning inside microfluidic devices. Biomed Microdevices (2007) 0.92

β-Amyloid is transmitted via neuronal connections along axonal membranes. Ann Neurol (2014) 0.92

Microfluidic-based strip assay for testing the effects of various surface-bound inhibitors in spinal cord injury. J Neurosci Methods (2008) 0.91

O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. Neurobiol Aging (2012) 0.91

Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway. Diabetes (2012) 0.90

CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver Int (2014) 0.90

Integrated microfluidics platforms for investigating injury and regeneration of CNS axons. Ann Biomed Eng (2012) 0.90

Fabrication of a microfluidic device for the compartmentalization of neuron soma and axons. J Vis Exp (2007) 0.90

Novel microfluidic platform for culturing neurons: culturing and biochemical analysis of neuronal components. Biotechnol J (2009) 0.90

Furin is an endogenous regulator of alpha-secretase associated APP processing. Biochem Biophys Res Commun (2006) 0.89

Human serum transthyretin levels correlate inversely with Alzheimer's disease. J Alzheimers Dis (2011) 0.89

Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J Neurosci (2012) 0.89

Examination of axonal injury and regeneration in micropatterned neuronal culture using pulsed laser microbeam dissection. Lab Chip (2010) 0.89

[A case of hepatoid carcinoma of the pancreas]. Korean J Gastroenterol (2006) 0.89

Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma. J Korean Med Sci (2010) 0.88

Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy (2012) 0.88

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease. Clin Mol Hepatol (2013) 0.87

Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters. Korean J Pathol (2013) 0.87

Micro-volume wall-less immunoassays using patterned planar plates. Lab Chip (2013) 0.86

A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation. Biomicrofluidics (2014) 0.86

Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation. Bioorg Med Chem Lett (2008) 0.86

Amyloid beta peptide directly inhibits PKC activation. Mol Cell Neurosci (2004) 0.86

Supraumbilical subcutaneous fat necrosis after transcatheter arterial chemoembolization with drug-eluting beads: case report and review of the literature. Cardiovasc Intervent Radiol (2012) 0.85

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis. Liver Transpl (2012) 0.85

Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice. Biochem Biophys Res Commun (2007) 0.85

Adipocyte induction of preadipocyte differentiation in a gradient chamber. Tissue Eng Part C Methods (2012) 0.85

Shear stress effect on transfection of neurons cultured in microfluidic devices. J Nanosci Nanotechnol (2009) 0.85

Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation. Bioorg Med Chem Lett (2006) 0.85

Accumulation of phosphorylated beta-catenin enhances ROS-induced cell death in presenilin-deficient cells. PLoS One (2009) 0.84

Profiling proteins related to amyloid deposited brain of Tg2576 mice. Proteomics (2004) 0.84

Clear cell chondrosarcoma in the nasal septum. Otolaryngol Head Neck Surg (2007) 0.84

Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1. Biochem Biophys Res Commun (2008) 0.84